Reimbursement Briefs: OIG, CMS Address DME; Cigna Genetic Testing Policy Takes Effect
This article was originally published in The Gray Sheet
OIG released reports pressing for reduced Medicaid payments on DME. Meanwhile, CMS delayed again the face-to-face requirement for DME reimbursement and updated its oxygen supplier policy. A new policy at insurer Cigna took effect to require genetic counseling prior to genetic testing for certain conditions.
You may also be interested in...
Reps. Glenn ‘GT’ Thompson, R-Pa., and Mike Thompson, D-Calif., have introduced legislation banning CMS from reimbursing unaccredited or unlicensed orthotics and prosthetics providers. The bill comes after a report, commissioned by the American Orthotic and Prosthetic Association, showed that CMS’ efforts to eliminate payments to unlicensed providers have been ineffective.
The 2014 federal budget request submitted by President Obama April 10 includes proposals to cut clinical lab services and to limit Medicaid reimbursement for durable medical equipment, among other cuts that would affect the medtech industry.
CMS To Pay Co-Surgeons For Transcatheter Valve Procedures, But At Lower Value Than Sought By Physicians
Surgeons and cardiologists who perform transcatheter aortic valve replacement procedures will be paid for the total amount of their work in 2013, but CMS’ adoption of a lower relative value unit for TAVR will result in a lower payment amount.